Compounds > 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Chronic Disease

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bluemke, DA; Davies-Venn, C; Kim, H; Kim, I; Kim, JS; Lee, SJ; Paik, CH; Yang, BY; Yao, Z1

Other Studies

1 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Chronic Disease

ArticleYear
64Cu-DOTA as a surrogate positron analog of Gd-DOTA for cardiac fibrosis detection with PET: pharmacokinetic study in a rat model of chronic MI.
    Nuclear medicine communications, 2016, Volume: 37, Issue:2

    Topics: Animals; Autoradiography; Chronic Disease; Copper Radioisotopes; Disease Models, Animal; Drug Stability; Electrons; Fibrosis; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Myocardial Infarction; Myocardium; Organometallic Compounds; Positron-Emission Tomography; Rats

2016